|1.||Laderoute, Keith R: 1 article (07/2009)|
|2.||Zaveri, Nurulain T: 1 article (07/2009)|
|3.||Jiang, Faming: 1 article (07/2009)|
|4.||Calaoagan, Joy: 1 article (07/2009)|
|5.||Sato, Barbara G: 1 article (07/2009)|
|6.||Murphy, Brian J: 1 article (07/2009)|
|1.||Lung Neoplasms (Lung Cancer)
07/01/2009 - "These inhibitory effects of SR13904 on tumor cells were linked to a G(1)/S cell cycle block and increased apoptosis. "
07/01/2009 - "The antitumor activities of SR13904 suggest that antagonism of PPARdelta-mediated transactivation may inhibit tumorigenesis and that pharmacological inhibition of PPARdelta may be a potential strategy for treatment or prevention of cancer."
07/01/2009 - "A novel peroxisome proliferator-activated receptor delta antagonist, SR13904, has anti-proliferative activity in human cancer cells."
|2.||Cell Cycle Proteins